---
title: "Migalastat - Fabry Disease"
sidebar: mydoc_sidebar
permalink: db05018-mesh-d000795-1.html
toc: false 
---


Path ID: `DB05018_MESH_D000795_1`
{% include image.html url="images/db05018-mesh-d000795-1.png" file="db05018-mesh-d000795-1.png" alt="db05018-mesh-d000795-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C090092">MESH:C090092 </a> | migalastat | Drug |
| <a href="https://identifiers.org/UniProt:P06280">UniProt:P06280 </a> | Alpha-galactosidase A | Protein |
| <a href="https://identifiers.org/GO:0046479">GO:0046479 </a> | glycosphingolipid catabolic process | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D013107">MESH:D013107 </a> | Sphingolipids | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D000795">MESH:D000795 </a> | Fabry Disease | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Migalastat | DECREASES ACTIVITY OF | Alpha-Galactosidase A |
| Alpha-Galactosidase A | POSITIVELY REGULATES | Glycosphingolipid Catabolic Process |
| Glycosphingolipid Catabolic Process | INCREASES ABUNDANCE OF | Sphingolipids |
| Sphingolipids | POSITIVELY CORRELATED WITH | Fabry Disease |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB05018#mechanism-of-action](https://go.drugbank.com/drugs/DB05018#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Migalastat](https://en.wikipedia.org/wiki/Migalastat)
  - [https://www.uniprot.org/uniprot/P06280#function](https://www.uniprot.org/uniprot/P06280#function)
  - [https://en.wikipedia.org/wiki/Fabry_disease](https://en.wikipedia.org/wiki/Fabry_disease)
